R&D Sponsored Solving for industry-wide clinical trial development challen... PurpleLab Managed Services empower clinical development teams to reduce risks and optimise trial execution.
Digital Sponsored Decoding prescriber behaviour: Insights from PurpleLab Launching a new pharmaceutical product is a high-stakes endeavour.
Digital Sponsored Decoding physician prescribing behaviour: A data-driven jour... Identifying high-volume prescribers and engaging with key opinion leaders (KOLs) in a target therapeutic area can be a challenge.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.